Skip to content
Menu

Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target

Benzinga Newsdesk 8 months ago

NewsPrice TargetAnalyst Ratings

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 price target.

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 price target.

Read at benzinga.com